Pluripotency distinguishes embryonic stem cells from adult stem cells found in adults while embryonic stem cells can generate all cell types in the body, adult stem cells are multipotent and can produce only a limited number of cell types.

These factors are extremely important for the efficiency of deriving ES cells.

Embryonic stem cells (ES cells) are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early stage preimplantation embryo.

So, in addition to human ES cell research, many groups are focused on the generation of induced pluripotent stem cells (iPS cells).

These embryos can be harvested for patient matching embryonic stem cells.

Derivation of embryonic stem cells from other animals Embryonic stem cells are derived from the inner cell mass of the early embryo, which are harvested from the donor mother animal.

In animals it is necessary to ensure that the inserted DNA is present in the embryonic stem cells.

But the moral controversy surrounding embryonic stem cells the fact that these cells are derived from five day old human embryos has encouraged research into other types of stem cells.

In common with embryonic stem cells, adult stem cells have the ability to differentiate into more than one cell type, but unlike the former they are often restricted to certain types or lineages .

If they are given the right chemical environment these cells have the same ability as embryonic stem cells to develop into many different cell types.

Neural crest stem cells Hair follicles contain two types of stem cells, one of which appears to represent a remnant of the stem cells of the embryonic neural crest.

And here is the limitation adult stem cells are mature cells, and, like mature human beings, these cells are more restricted in their thought and more restricted in their behavior and are unable to give rise to the wide variety of specialized cell types, as embryonic stem cells can .

Embryonic stem cells have occupied center stage, chiefly because of their pluripotency that is their ease in differentiating into a variety of different cell types.

The other main theory is that fetal cells home to injured or diseased maternal tissue where they act as stem cells and participate in repair.

In 1981, embryonic stem cells (ES cells) were independently first derived from mouse embryos by two groups.

And at that time, stem cell research had gained momentum, following the isolation of the world's first human embryonic stem cells in the 1990s.

It is now known that the feeder cells provide leukemia inhibitory factor (LIF) and serum provides bone morphogenetic proteins (BMPs) that are necessary to prevent ES cells from differentiating.

Gail R. Martin, from the Department of Anatomy, University of California, San Francisco, published her paper in December and coined the term Embryonic Stem Cell .

Since this discovery occurred in 1999, ES cells have become a key tool in the generation of specific chimeric mice.

This technical achievement would potentially enable scientists to work with new lines of embryonic stem cells derived using public funding in the USA, where federal funding was at the time limited to research using embryonic stem cell lines derived prior to August 2001.

We can now reprogram your skin cells to actually act like a pluripotent embryonic stem cell and to utilize those potentially to treat multiple organs in that same patient making your own personalized stem cell lines.

They discovered that adult cells, taken from you and me, could be reprogrammed back into embryonic like cells, which they termed IPS cells, or induced pluripotent stem cells.

For example stem cell treatments involve the harvesting of stem cells from one's own bone marrow and reintroduction (autoinoculation) of those cells at a later date, sometimes after altering those stem cells.

Adult stem cells are throughout our body, including the blood forming stem cells in our bone marrow, which we've been using as a form of stem cell therapy for over 40 years.

Martin Evans and Matthew Kaufman from the Department of Genetics, University of Cambridge published first in July, revealing a new technique for culturing the mouse embryos in the uterus to allow for an increase in cell number, allowing for the derivation of ES cells from these embryos.

In 1998, a breakthrough occurred when researchers, led by James Thomson at the University of Wisconsin Madison, first developed a technique to isolate and grow human embryonic stem cells in cell culture.

Ms. Katungye (Uganda) Uganda voted in favour of the draft Declaration on Human Cloning because, as a nation, we are firmly opposed to all forms of cloning that involve the destruction of embryonic stem cells and erode respect for and the protection of human dignity.

A number of studies have investigated the possibility of identifying specific markers that may distinguish CSCs from the bulk of the tumor (as well as from normal stem cells).

Mammary stem cells Mammary stem cells provide the source of cells for growth of the mammary gland during puberty and gestation and play an important role in carcinogenesis of the breast.

The role of Bmi 1 has also been illustrated in neural stem cells.

Fetal cells have been documented to persist and multiply in the mother for several decades.

After giving birth, about 50 75 of women carry fetal immune cell lines.

The most important difference between stem cells and progenitor cells is that stem cells can replicate indefinitely, whereas progenitor cells can divide only a limited number of times.

Stem cells provide hope for new beginnings small, incremental steps, cells rather than organs, repair rather than replacement.

Nor will it affect the United Kingdom's strong support of stem cell research.

Potential method for new cell line derivation On August 23, 2006, the online edition of Nature scientific journal published a letter by Dr. Robert Lanza (medical director of Advanced Cell Technology in Worcester, MA) stating that his team had found a way to extract embryonic stem cells without destroying the actual embryo.

Typically, this is done in mice since the technology for this process is more refined, and because mouse embryonic stem cells are easily manipulated.

This is because cancer stem cells are isolated from end stage tumors.

However, not every cell in the tumor has the ability to metastasize.

Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.

2007 Nobel prize Mario R. Capecchi, Martin J. Evans and Oliver Smithies were declared laureates of the 2007 Nobel Prize in Physiology or Medicine for their work on principles for introducing specific gene modifications in mice by the use of embryonic stem cells , or gene targeting.

It is a rich source of hematopoietic stem cells, which are precursors to blood cells.

What fraction of tumor cells are CSCs and therefore need to be eliminated is not clear yet.

It has hosted several international conferences in the fields of biotechnology, nanotechnology, and stem cell research.

The embryos were allowed to develop for several days in a laboratory setting, then destroyed to harvest the resulting stem cells.